搜索到 1000 条关于 유튜브 ts 업로드 vsa822.top 백링크 프로그램 키보드 반복 매크로 그래픽카드 판매 sq 的文章

肿瘤相关静脉血栓栓塞症预防与治疗中国专家指南 2015

2016.03.25 肿瘤相关静脉血栓栓塞症预防与治疗中国专家指南 2015

血小板计数监测结合 4Ts 评分在接受肝素或低分子肝素治疗患者中的应用(1)对于接受肝素治疗但临床医生预测其发生 HIT 的风险>1.0% 的患者,建议在第
丁香园通讯员现场采访陆嘉德教授

2007.09.21 丁香园通讯员现场采访陆嘉德教授

TS, Wynne CJ. Cultural attitudes to cancer management in traditional south-east

2012.09.19 2011年生物仿制药会议(Biosimilars Asia 2011)

时间: 2011-5-23 至 2011-5-26
地点:Grand Hyatt Shanghai
主办单位: IBC Asia (S) Pte Ltd

会议简介

According to Business Insights, an estimated $25bn worth of biologics will lose patent protection by 2016, creating a significant market opportunity for biosimilars. However, the reality is that biosimilar development is a risk-fraught activity that demands significant resources in R&D, manufacturing expertise, regulatory know-how, clinical-trial capabilities, and a high level of financial investment.

Biosimilar development is riddled with complexities, ranging from regulatory, to manufacturing to marketing, and is one of the most expensive propositions in the pharmaceutical industry. It is estimated that it costs between US$100-200 million to bring a biosimilar product to market. With so much at stake, biosimilars represent not only substantial growth but equally risk..

IBC’s 2nd Annual Biosimilars Asia 2011 Summit is the ONLY conference in Asia catering to this region’s specific queries. With unprecedented insights from leading innovators and biosimilar companies, you will network and learn how to strategically position your company to maximize your ROI. Biosimilars Asia 2011 is attended by key stakeholders in the region and beyond, enabling you to make informed strategic decisions.

5 Reasons To Attend
  • Only conference in Asia which addresses concerns faced by the Asian biosimilar companies with experts from the region and beyond
  • Learn from and personally meet senior executives from the major stakeholders amongst from biosimilar to innovator companies
  • The most comprehensive event highlighting key challenges in the industry including manufacturing, marketing, pricing, transitioning from generics to biosimilars and regulatory issues
  • Showcasing unique case studies from leading Asian and international biosimilar companies
  • Gather the latest insights from regional biosimilar companies and MNCs about their strategic decisions and how they are positioning themselves for success

Industry Gurus / Speakers
Biocon, Pfizer, Genentech, Roche, Teva, Hospira, Sandoz, Momenta, Intas, Dr Reddy’s, Shenzhen Main Luck Pharmaceuticals

Past Attendees Include
Vice President, ASTRAZENECA INNOVATION CENTER (China)
Senior Director, GENENTECH INC, (USA)
Managing Director, BECTON DICKINSON CO (BD BIOSCIENCES) (Singapore)
Managing Director, ASAHI GLASS CO LTD (Japan)
Deputy General Manager, SINOPHARM (China)
Head, Biotech Research, USV LTD (India)
General Manager, JCR PHARMACEUTICALS CO LTD (Japan)
Vice President, R&D/Business Development, MAIN LUCK PHARMACEUTICALS INC (China)
Senior Research Associate, HANWHA CHEMICAL (South Korea)
Vice President, BOEHRINGER INGELHEIM GMBH (Germany)
General Manager, GLAXOSMITHKLINE (CHINA) INVESTMENT CO LTD (China)
IP Director, HOSPIRA (AUSTRALIA)
President, MYCENAX BIOTECH INC (Taiwan)
Senior Director, MERCK & CO INC (USA)
Associate Director, DR REDDY''''''''S LABORATORIES LTD (India)
Chairman, SHENZHEN SCIPROGEN BIO-PHARMACEUTICAL CO LTD (SCIPROGEN) (China)COO, SHANGHAI CELGEN BIOPHARMACEUTICALS (China)
Chief Representative, TTY BIOPHARM CO LTD (Taiwan)COO, 3SBIO (China)
Project Director, JIANGSU CHIA TAI TIANQING PHARMACEUTICAL CO LTD (China)Associate Director, PFIZER INVESTMENT CO LTD (China)
General Manager, NIPPON KAYAKU CO LTD (Japan)
President, HENLIUS BIOPHARMACEUTICALS INC & SHANGHAI HENLIUS BIOTECH (USA)
Vice President, RANBAXY (USA)

Registration

FEES per delegate
Early Bird Rate
Register & Pay before 11 March 2011
Special Rate
Register & Pay before 15 April 2011
Normal Rate
Register & Pay after 15 April 2011
Group Rate
Group of 3 or more
?
US$ / CNY
US$ / CNY
US$ / CNY
US$ / CNY
4 day package
(Conf + Pre & Post Workshops)
2,495 /
16,600
2,695 /
17,950
2,895 /
19,500
2,175 /
14,650
3.5 day package (Conf + Workshop C & A or B )

2,295 /
15,500

2,495 /
16,600
2,695 /
17,950
2,025 /
13,500
3 day package (Conf + Workshop A & B or C)
1,995 /
13,500
2,195 /
14,600
2,395 /
15,950

1,795 /
12,000

2.5 day package (Conf + Workshop A or B)
1,795 /
12,000
1,995 /
13,500
2,195 /
14,600
1,695 /
10,950
2 day package
(Conf only)
1,495 /
9,950
1,695 /
11,300
1,895 /
12,600
1,495 /
9,950

Register Now

PAYMENT TERMS

Payment must be received 10 business days prior to the event. To take advantage of discounts with an expiry cut-off date, registration and payment must be received by the cut off date.

Payments by Singapore Dollars (S$)

  • Payments by S$ bank draft or cheque should be made in favour of “IBC Asia (S) Pte Ltd” payable in Singapore.
  • Payment by telegraphic transfer in S$ must be made to:
    IBC Asia (S) Pte Ltd
    A/C No.: 147-059513-001 (SGD)
    The Hongkong and Shanghai Banking Corporation Limited
    21 Collyer Quay, HSBC Building, Singapore 049320
    Bank Swift Code: HSBCSGSG
    Bank Code: 7232
  • Payment by Credit Card (AMEX, VISA or MASTERCARD). Please provide your Card Number, Name of Cardholder, Expiry Date and your Signature and send it by fax to +65 6508 2407.
Payments by RMB (CNY)
  • Payment by telegraphic transfer in CNY must be made to:
    A/C Name:
    A/C No.: 720-031103-001
    Beneficiary Bank:
    Bank Address: No. 1000 Lujiazui Rind Road,
    Pudong, Shanghai 200120, P.R. China
    Bank Swift Code: HSBCCNSH
CANCELLATIONS SUBSTITUTION
Should you be unable to attend, a substitute delegate is welcome at no extra charge. Cancellations must be received in writing at least 10 business days before the start of the event, to receive a refund less 10% processing fee per registration. The company regrets that no refund will be made available for cancellation notifications received less than 10 business days before the event.IMPORTANT NOTE:
Please quote the name of the delegate, event title and invoice number on the advice when remitting payment. Bank charges are to be deducted from participating organisations own accounts. Please fax your payment details (copy of remittance advice, cheque or draft to +65 6508 2407.

Attendance will only be permitted upon receipt of full payment. Participants wishing to register at the door are responsible to ensure all details are as published. IBC Asia will not be responsible for any event re-scheduled or cancelled.


DATA PROTECTION
The personal information entered during your registration/order, or provided by you, will be held on a database and may be shared with companies in the Informa Group in the UK and internationally. Sometimes your details may be obtained from or shared with external companies for marketing purposes. If you do not wish your details to be used for this purpose, please contact Winnie Seah (Database) on winnie.seah@ibcasia.com.sg Tel: +65 6508 2468 or Fax: +65 6508 2408.
联系方式电话:+65 650 82401
8月,医生都在反复看这几篇好文章

2018.09.12 8月,医生都在反复看这几篇好文章

这一期《月度好文精选》来晚啦,因为药药忙着处理「专业版拼团」活动的用户反馈。虽然晚了一些,但我保证,这一期好文章绝对超值!8 月用药经验 TOP 5《临床医生...给药?》《五张表教你同类药物如何等效剂量换算》8 月用药问答 TOP 5《用药问答:输液时突然休克,谁是罪魁祸首?》《用药问答:急诊遇糖尿病急性并发症
重磅:2017 儿科领域 SCI 期刊影响因子出炉

2017.06.13 重磅:2017 儿科领域 SCI 期刊影响因子出炉

2017 年 6 月 13 日,备受瞩目的 2016 SCI 期刊影响因子正式发布,儿科领域的各期刊的 IF 值有何变化?一起来看下吧。儿科领域 Top 10...。儿科领域Top 30至于第 19 名,儿科君搜了去年的前 50 也没找到,只能说是一匹黑马。。。具体查询方法进入网站:web of science
GraphPad Prism 绘制箱形图美化技巧

2017.02.14 GraphPad Prism 绘制箱形图美化技巧

界面:依次选中 Data1:C:C,Reorder,Up 三个选项至 Data1:C:C 上升至第一列,再点击 OK(或者直接点击 Top,置于顶端也可以得到... 下移,Top 置于顶端,Bottom 置于底端,Reverse 反转数据列顺序(即顺序有 ABCDE 改变为 EDCBA)。此外,进入 Format Graph
带心灵去旅行「精神食粮」送不停

2016.10.01 带心灵去旅行「精神食粮」送不停

推荐书」的 TOP.5 榜单吧!这是根据「医生阅读行为」调研活动中的 2102 份有效问卷得出的榜单,有很多医生推荐同行看这些书。看了医生推荐的 Top
与去年相比  全球在研新药呈现哪些变化?

2016.07.28 与去年相比 全球在研新药呈现哪些变化?

、生物技术类药物、神经系统药物、抗感染药物和复方药物为排名居 TOP 5 的治疗领域。其中,癌症仍是药品研发的核心领域,抗癌/抗肿瘤药物数量呈现显著增长态势,数量...,与 2015 年数据进行对比,可反映不同治疗类别在研药物数量的变化情况。从治疗类别 TOP 25 排名中发现,一般抗癌药 (在研药物 2071 个)、免疫类

2012.09.19 2010 第五届国际基因组学大会(ICG-V)

, please click: http://www.genomeconference.org/pages/Abstract.aspxTop Poster

2020.06.17 【直播 | 现场】计算机辅助设计—分子模拟与蛋白互作研讨班(8.20-22)

。【报名回执】访问此链接填写报名回执(https://www.wjx.top/jq/80710449.aspx)【咨询请联系】QQ 号:2814500767邮箱

2012.09.19 2012 中国医疗器械高峰论坛

trials and regulatory affairs
A special showcase of top 10 Chinese innovative device companies and top 5 selected US/EU device companies interested in China
2021 年 6 月最受欢迎的品牌案例

2021.08.02 2021 年 6 月最受欢迎的品牌案例

本期「TOP list ·月度案例评选」是基于 6 月在丁香园医院汇平台上发布的文章,根据阅读量及点赞量呈现医疗行业「最受欢迎的品牌案例」TOP 10。医院汇努力为医疗行业从业者打造优秀品牌案例库,供行业宣传人士参考学习,也是众医院打造品牌曝光的重要营地。新闻资讯 TOP 10排名医院
2020 年 6 月最受欢迎的品牌案例

2020.06.30 2020 年 6 月最受欢迎的品牌案例

本期「TOP list ·月度案例评选」是基于 6 月在丁香园 医院汇 平台上发布的文章,根据阅读量及点赞量呈现医疗行业「最受欢迎的品牌案例」TOP 10。医院汇努力为医疗行业从业者打造优秀品牌案例库,供行业宣传人士参考学习,也是众医院打造品牌曝光的重要营地。新闻资讯 TOP 10
丁香园力荐 最受医生欢迎的 20 本必备好书

2015.11.14 丁香园力荐 最受医生欢迎的 20 本必备好书

「借花献佛」,和大家分享下推荐最多的 10 本 「案头必备」和 10 本 「床头必备」好书。一、案头必备TOP 1. 实用内科学推荐理由:中国医学界唯一一部畅销...出版一次,已出至第14版,可及时反映国内外进展,是内科领域各级学科医师的 「不二宝典」。TOP 2. 坎贝尔骨科手术学推荐理由:国际权威骨科经典著作,内含众多
2013年5大重磅新药

2013.12.27 2013年5大重磅新药

2013年岁末已至,回首这一年,一批「重磅炸弹」级新药的诞生,使得生物制药成为全球医药领域的一个焦点。Top1 默克...晚期黑色素瘤临床试验和非小细胞肺癌试验结果提交给监管机构。Top2 糖尿病治疗的新突破强生和Evotec公司共同开发
盘点2013年改变世界的5大重磅新药

2013.12.25 盘点2013年改变世界的5大重磅新药

2013年岁末已至,回首这一年,一批"重磅炸弹"级新药的诞生,使得生物制药成为全球医药领域的一个焦点。Top...积极的数据。制药巨头正准备将晚期黑色素瘤临床试验和非小细胞肺癌试验结果提交给监管机构。Top2:糖尿病治疗的新突破强生和Evotec公司

2012.09.19 2012个体化用药前沿研讨会

2012个体化用药前沿研讨会将于2012年11月15日~16日在上海召开。

随着药效差异、药物不良反应、药物临床试验和新药开发的损失等问题的日益严重,基因组学、蛋白组学、诊断学、纳米技术等科学技术的迅速发展,国内外个体化药物治疗纷纷启动,标志着个体化用药时代已经到来,但同时医疗体制及政策的不完善、基础研究及临床应用还有待探索等问题使得个体化用药之路充满了机遇和挑战。

本次会议正是为促进我国个体化用药研究成果转化与临床应用而举办,拟将邀请医药相关部门领导、国内著名医药科研及临床专家、跨国制药企业代表,针对个体化用药的行业进展与趋势、政策法规及管理规范、最新诊断技术、个体化药物临床应用、个体化药品研发与安全监测等热点议题进行广泛讨论,旨在促进政府、科研单位、医疗机构、企业等多方交流与合作,推动我国个体化用药与转化医学的健康发展。

为此,我们热忱的邀请您参加本次研讨会,与您相聚在上海!

会议简介

时间:2012年11月15日~16日

地点:上海青松城大酒店

规模:400人

主办单位:中国医师协会

联合主办:上海交通大学Bio-X研究院

承办单位:生物谷

大会主席:贺林

演讲嘉宾
姓名单位姓名单位
Edwin Wang加拿大国家科学院/麦吉尔大学的生物信息学中心缪丽燕苏州大学附属第一医院
蔡卫民复旦大学药学院沈 琳北京大学肿瘤医院
陈 超西北大学石远凯中国医学科学院肿瘤医院
杜智敏哈尔滨医科大学附属第二医院汪道文武汉同济医院
顾东风北京阜外医院王红阳上海东方肝胆外科医院
贺 林复旦大学生物医学研究院曾 瑄北京协和医院
黄 民中山大学药学院翟所迪北京大学第三医院
姜 红复旦大学附属中山医院周国华南京军区总医院药理科
康熙雄北京天坛医院周宏灏中南大学临床药理研究所


日程与主题(最终日程以会议当天为准)

2012年11月14日 星期三
09:00-22:00注册签到
2012年11月15日 星期四
08:30-12:30行业进展与趋势
个体化用药实施与展望;研究策略和思路;伦理和法规
诊断技术与个体化用药
个体化诊断临床管理规范;基因多态性检测信息解读及临床应用;个体化用药基因诊断产品与技术
12:30-13:30午餐(集体合影)
13:30-17:00个体化用药临床应用——肿瘤专场
肿瘤个体化用药及有关检测;肿瘤的分子靶向治疗;肿瘤化疗中的个体化用药
17:00-18:00专题讨论(Panel Discussion I)
2012年11月16日 星期五
08:30-12:30个体化用药临床应用——心血管疾病专场
心血管病的药物基因组学与个体化用药;玻力维、华法林的个体化应用
12:30-13:30午餐
13:30-17:00药物研发与个体化用药
药物不良反应的遗传药理学;药物基因组学、药物监测与个体化用药;个体化用药研发策略
17:00-17:30专题讨论(Panel Discussion II)
17:30大会闭幕
2012个体化用药前沿研讨会Ⅰ类学分继续医学教育4分

报名参会

联系人:张依寒 电话:86(21)54481353 Mt:13361952955

大会网址:www.bioon.com/z/Individualmed

上一页 1 2 3 ... 48 49 50 到第